| Program Description The oncology residency program at the Huntsman Cancer Institute (HCI) at the University of Utah is an intensive one-year clinical training program. HCI is an academic National Cancer Institute (NCI)-designated comprehensive cancer center and National Comprehensive Cancer Center (NCCN) member institution. The resident will develop an extensive knowledge base and problem-solving skills through an array of clinical experiences in acute and ambulatory care settings. The resident will be involved in maintaining and improving oncology practice by providing pharmacy services in various areas. Upon completion of the residency, the resident will be well prepared to practice in a variety of oncology settings. The program is accredited by the American Society of Health-System Pharmacists.
Program Goals
•Demonstrate a high level of professional responsibility, dedication, skill and maturity to practice in an oncology clinical environment.
•Develop a working knowledge of the biology of neoplasia which is evolving medication therapy in the field of oncology.
•Attain a level of didactic knowledge that will enable the resident to pass the Board Certified Oncology Pharmacist (BCOP) exam (with further study of at least statistics, drug literature evaluation, practice management, public health and advocacy concepts likely necessary).
•Serve as a role model and instructor for undergraduate and graduate students, and for practicing pharmacists.
•Demonstrate the motivation and responsibility for self-directed, independent study and learning.
•Clearly, concisely, effectively, and appropriately communicate, both verbally and in writing, with health care professionals and with patients.
•Develop a skill set of practice that assures competent practice in a variety of oncology settings.
Rotation Experiences
Required experiences include inpatient hematology, oncology, and blood & marrow transplant; outpatient clinics, oncology infusion, infectious disease, investigational drug services, and management. Electives include oncology-specific intensive care, pain and palliative care, pediatric oncology and stem cell transplant, and drug information among others. See here for further rotation information. See also here for a sample of resident scheduling possibilities, and here for a list of oncology-specific pharmacists. If interested in non-residency information about the Huntsman pharmacy department, please see our website here.
Teaching & Learning Opportunities
The resident will lead a variety of weekly formal topic discussions (6 per resident, in addition to topic discussions on rotation). Each resident will prepare content for both the college of pharmacy oncology pharmacotherapeutics module and the new oncology elective course, and is allowed to participate in additional lecture and/or recitation opportunities if interested. Residents participate in weekly discussions regarding the fundamentals of neoplastic disease biology and therapeutics through a review of a biology of cancer textbook along with drug class & pathway review articles. Each resident will prepare and present a 1-hour ACPE-accredited continuing education program. Additional opportunities are available through student and resident precepting and/or mentoring, multidisciplinary in-services, oncology fellows’ conferences, journal clubs, and an optional teaching certificate program.
For more information, see our website.
For more information contact: Stephanie A. Sanders, BS, PharmD, BCOP
Residency Program Director, PGY2 Oncology
Clinical Pharmacist, Oncology Intensive Care
Adjunct Instructor, College of Pharmacy
Stephanie.Sanders@hci.utah.edu
(801) 213-4293
Sara Hiller deHoll, PharmD, BCOP
Residency Coordinator, PGY2 Oncology
Clinical Pharmacist, Oncology Intensive Care & Inpatient
Hematology, Oncology Clinics
Adjunct Instructor, College of Pharmacy
Sara.Hiller@hci.utah.edu
(801) 213-4293
|
